西点药业
(301130)
| 流通市值：15.95亿 | | | 总市值：20.67亿 |
| 流通股本：5901.74万 | | | 总股本：7649.47万 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 101,427,291.82 | 55,925,260.77 | 234,840,419.16 | 188,945,385.6 |
| 营业收入 | 101,427,291.82 | 55,925,260.77 | 234,840,419.16 | 188,945,385.6 |
| 二、营业总成本 | 97,477,784.53 | 48,180,633.12 | 222,490,004.98 | 159,135,919.32 |
| 营业成本 | 26,277,574.95 | 15,141,067.29 | 55,742,404.81 | 41,512,253.73 |
| 税金及附加 | 3,627,376.31 | 1,712,417.82 | 7,239,263.27 | 5,476,290.7 |
| 销售费用 | 41,483,024.34 | 19,148,834.58 | 112,226,061.66 | 74,798,184.74 |
| 管理费用 | 20,838,919.46 | 9,731,367.52 | 36,010,672.44 | 29,393,766.93 |
| 研发费用 | 4,967,873.7 | 2,363,952.48 | 11,253,072.96 | 7,978,718.67 |
| 财务费用 | 283,015.77 | 82,993.43 | 18,529.84 | -23,295.45 |
| 其中:利息费用 | 353,653.66 | 127,202.36 | 444,830.96 | 362,725.03 |
| 其中:利息收入 | 80,854.9 | 47,824.87 | 450,018.99 | 407,071.91 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 292,652.04 | -79,845.07 | 938,341.28 | 551,037.55 |
| 加:投资收益 | 755,372.5 | 259,711.04 | 2,996,300.69 | 2,552,898.35 |
| 资产减值损失(新) | -65,398.36 | -17,087.33 | -994,022.64 | -71,366.75 |
| 信用减值损失(新) | -152,387.17 | -238,633.48 | 160,340.94 | -407,365.7 |
| 其他收益 | 3,306,658.64 | 2,122,008.01 | 4,769,387.96 | 3,667,779.69 |
| 四、营业利润 | 8,086,404.94 | 9,790,780.82 | 20,220,762.41 | 36,102,449.42 |
| 加:营业外收入 | 289,675.75 | 286,394.99 | 782,035.46 | 68,000.81 |
| 减:营业外支出 | 345,524.39 | 113,747.09 | 6,629.43 | 6,006.83 |
| 五、利润总额 | 8,030,556.3 | 9,963,428.72 | 20,996,168.44 | 36,164,443.4 |
| 减:所得税费用 | 208,341.74 | 1,360,700.29 | 1,098,115.87 | 4,812,174.71 |
| 六、净利润 | 7,822,214.56 | 8,602,728.43 | 19,898,052.57 | 31,352,268.69 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 7,822,214.56 | 8,602,728.43 | 19,898,052.57 | 31,352,268.69 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 8,927,235.93 | 9,184,829.82 | 21,900,019.04 | 33,146,362.42 |
| 少数股东损益 | -1,105,021.37 | -582,101.39 | -2,001,966.47 | -1,794,093.73 |
| 扣除非经常损益后的净利润 | 6,745,622.62 | 8,043,957.02 | 17,537,029.35 | 29,808,580.48 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.12 | 0.12 | 0.29 | 0.43 |
| (二)稀释每股收益 | 0.12 | 0.12 | 0.29 | 0.43 |
| 九、综合收益总额 | 7,822,214.56 | 8,602,728.43 | 19,898,052.57 | 31,352,268.69 |
| 归属于母公司股东的综合收益总额 | 8,927,235.93 | 9,184,829.82 | 21,900,019.04 | 33,146,362.42 |
| 归属于少数股东的综合收益总额 | -1,105,021.37 | -582,101.39 | -2,001,966.47 | -1,794,093.73 |
| 公告日期 | 2026-08-26 | 2026-04-29 | 2026-04-29 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |